Jupiter Life Line Hospitals Limited (NSE:JLHL)
India · Delayed Price · Currency is INR 1,467.00
+2.90 (0.20%)
Jul 10, 2026, 3:30 PM IST
NSE:JLHL Stock Forecast
Stock Price Forecast
According to 6 analysts polled by S&P Global, NSE:JLHL stock has a consensus rating of "Strong Buy" and an average price target of ₹1,596. The average 1-year stock price forecast is 8.78% higher than the current stock price, while the lowest is ₹1,475 (+0.55%) and the highest is ₹1,695 (+15.54%).
Price Target: ₹1,596 (+8.78%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for NSE:JLHL stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 6 | 6 |
| Buy | 1 | 1 | 1 | 1 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 6 | 6 |
Financial Forecast
Revenue This Year
18.22B
from 15.00B
Increased by 21.47%
Revenue Next Year
21.37B
from 18.22B
Increased by 17.31%
EPS This Year
34.47
from 30.14
Increased by 14.34%
EPS Next Year
43.22
from 34.47
Increased by 25.39%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.
Revenue Forecast
| Revenue | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 20.6B | ||
| Avg | 18.2B | ||
| Low | 16.9B |
Revenue Growth
| Revenue Growth | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 37.3% | ||
| Avg | 21.5% | ||
| Low | 12.5% |
EPS Forecast
| EPS | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 41.90 | ||
| Avg | 34.47 | ||
| Low | 29.40 |
EPS Growth
| EPS Growth | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 39.0% | ||
| Avg | 14.3% | ||
| Low | -2.5% |